Search results
Erythromycin is an antibiotic used for the treatment of a number of bacterial infections. [1] This includes respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis. [1] It may also be used during pregnancy to prevent Group B streptococcal infection in the newborn, [1] and to improve delayed ...
- C₃₇H₆₇NO₁₃
- AU: A
- liver (under 5% excreted unchanged)
- Eryc, Erythrocin, others
Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of [ Azithromycin ], [ Clarithromycin ], [ Spiramycin] and others. It was originally discovered in 1952.
Erythromycin. Erythromycin is a wide-spectrum antibiotic that was first isolated by J. M. McGuire and co-workers from a strain of the bacterium Streptomyces erythreus (now called Saccharopolyspora erythraea) found in a soil sample from the Philippines. Its action is similar to that of penicillins.
Erythromycin is a macrolide that acts by inhibiting the translocation reaction during protein synthesis. Erythromycin is inactive against the Enterobacteriaceae and Pseudomonas aeruginosa except under alkaline conditions. Erythromycin is active against most gram-positive bacteria; some gram-negative bacteria, including Neisseria, Bordetella, Brucella, Campylobacter, and Legionella; and ...
- John A. Washington, Walter R. Wilson
- 1985
Apr 12, 2024 · erythromycin, drug synthesized by the soil bacterium Streptomyces erythraeus and used in the treatment of throat infections, pneumonia, and other diseases.Erythromycin, an antibiotic that inhibits the synthesis of vital proteins in susceptible bacteria, may be either bacteriostatic (i.e., inhibiting bacterial reproduction but not killing bacterial cells) or bactericidal (i.e., killing bacteria ...
- The Editors of Encyclopaedia Britannica
Abstract. Erythromycin is an antibiotic which inhibits the growth of many Gram- positive and some Gram-negative organisms and is especially successful against group A streptococcal, staphylococcal, and pneumococcal infections. The bacteriostatic action of erythromycin is a result of the antibiotic’s ability to selectively inhibit protein ...
Erythromycin, first introduced for clinical use 30 years ago, was found to be effective for the treatment of gram-positive bacterial infections. Emergence of resistance and the advent of penicillinase-resistant penicillins limited the use of erythromycin for serious staphylococcal infections; however, erythromycin remains among the drugs of choice for the treatment of acne, infections of the ...
